Press Releases :: OPKO Health, Inc. (OPK)

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Read the news release

Visit BioReference Health

Year

Category

Feb 3, 2021 9:01 am EST

OPKO Health to Report Fourth Quarter 2020 Financial Results on February 18, 2021

Jan 28, 2021 8:00 am EST

New Drug Application Submitted to PMDA in Japan for Somatrogon, to Treat Pediatric Patients with Growth Hormone Deficiency

Jan 26, 2021 8:30 am EST

OPKO Health’s GeneDx Adds Repeat Expansion Analysis Genetic Tests for Diagnosis of Spinocerebellar Ataxia (SCA), Friedreich Ataxia, and Other Common Forms of Hereditary Ataxia

Jan 26, 2021 8:00 am EST

OPKO Health's BioReference Laboratories Team-up with the National Basketball Association and National Hockey League to Provide Players and Staff with COVID-19 Testing

Jan 13, 2021 3:40 pm EST

OPKO Health's BioReference Laboratories Introduces Scarlet Health™, an In-Home Diagnostic Service to Expand Digital Health Access

Jan 5, 2021 8:00 am EST

OPKO Health to Present at the 39th Annual J.P. Morgan Healthcare Conference

Jan 4, 2021 3:08 pm EST

US FDA Accepts Regulatory Submission from Pfizer and OPKO for Review of Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency

Jan 4, 2021 12:05 pm EST

OPKO Health's BioReference Laboratories Reports Results of the Largest COVID-19 Public School Testing Program Nationwide

Dec 31, 2020 8:30 am EST

Buffalo Bills and OPKO Health's BioReference Laboratories Initiate the First Large Scale, Mandatory COVID-19 Fan Testing Program

Dec 21, 2020 8:00 am EST

OPKO Health Appoints Dr. Roger Medel to its Board of Directors